Navigation Links
Coronado Biosciences to Present at the Oppenheimer 22nd Annual Healthcare Conference
Date:12/7/2011

BURLINGTON, Mass., Dec. 7, 2011 /PRNewswire/ -- Coronado Biosciences, Inc., (OTCBB: CNDO), a biopharmaceutical company focused on the development of novel immunotherapy agents for the treatment of autoimmune diseases and cancer, today announced that Dr. Bobby W. Sandage, Jr., the Company's President, Chief Executive Officer and Director, will present at the Oppenheimer 22nd Annual Healthcare Conference on Wednesday, December 14, 2011 at 10:30 AM ET.  The conference will be held at The Waldorf-Astoria Hotel in New York City on December 13-14, 2011.

A webcast of this presentation will be available at www.coronadobiosciences.com on the events page. 

About Coronado Biosciences

Coronado Biosciences is engaged in the development of novel immunotherapy biologic agents.  The Company's two principal pharmaceutical product candidates in clinical development are: CNDO-201, a biologic for the treatment of autoimmune diseases, such as Crohn's disease, ulcerative colitis and multiple sclerosis; and CNDO-109, a biologic that activates natural killer (NK) cells, for the treatment of acute myeloid leukemia (AML) and solid tumors.  For more information, please visit www.coronadobiosciences.com. 

Forward-Looking Statements

This press release may contain "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934.  Such statements include, but are not limited to, any statements relating to the Company's product development programs and any other statements that are not historical facts. Forward-looking statements are based on management's current expectations and are subject to risks and uncertainties that could negatively affect our business, operating results, financial condition and stock price. Facto
'/>"/>

SOURCE Coronado Biosciences, Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Monogram Biosciences to Present at the Thomas Weisel Partners Healthcare Conference 2008
2. Carna Biosciences Signs Reagent Supply Agreement with Caliper Life Sciences
3. Pressure BioSciences, Inc. to Discuss Second Quarter 2008 Financial Results and Provide Business Update
4. Milestone Biosciences, LLC Further Strengthens Executive Management Team
5. Pressure BioSciences, Inc. Reports Second Quarter 2008 Financial Results and Provides Business Update
6. Access Pharmaceuticals Licenses MuGard to Milestone Biosciences, LLC for North America
7. Pressure BioSciences, Inc. Releases Novel, PCT-dependent Sample Preparation Kit for Systems Biology Studies
8. Neurocrine Biosciences to Present at Thomas Weisel Healthcare Conference and the NewsMakers in the Biotech Industry Conference
9. Start-Up and Emerging Biotech Companies Will Tell Their Stories at Biosciences Showcase Planned for MichBio Expo
10. Ardea Biosciences to Present Data on Lead MEK inhibitor, RDEA119, at EORTC-NCI-AACR Symposium
11. Pressure BioSciences, Inc. Announces Research Agreement With the US Army Medical Research Institute of Infectious Diseases (USAMRIID)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/18/2013)... The human skin is the largest organ, yet many do ... Similar to the liver, or heart, the skin must be ... Recent reports from the mankatofreepress.com explained how caring for the ... other life supporting organs. The article suggests several types of ... the appearance of skin, and fight off acne causing factors. ...
(Date:6/18/2013)... JERUSALEM , June 18, 2013 ... study using the company,s  proprietary AMCA Guided Bone Regeneration (GBR) ... dental implants. A common problem encountered when patients ... lack of sufficient bone volume to house the implant. Consequently ... a bone substitute until the natural bone regenerates. The bone ...
(Date:6/18/2013)... LONDON , June 18, 2013 /PRNewswire/ ... leading international investment research firm, announces the ... (BIO.PA), a French biopharmaceutical company developing and ... supportive care indications.      (Logo: ... a comprehensive report examining the investment merits ...
(Date:6/18/2013)... Israel , June 18, 2013 ... Active Pharmaceutical Ingredients (APIs), generic and innovative intermediates, and finished ... that the company has been granted a United ... the US and Europe for the ... number 8,410,176 B2 is titled Intermediate Compounds and Processes ...
Breaking Biology Technology:Natural Acne Remedies Through Diet, Probiotic Action Shares New Insight on What Foods May Help Lead to Clear Skin 2RegeneCure Starts Clinical Study Using Polymeric Bone Stimulating Membrane for Dental Implants 2RegeneCure Starts Clinical Study Using Polymeric Bone Stimulating Membrane for Dental Implants 3Edison Expands French Healthcare Sector Coverage With Initiation of Coverage on BioAlliance Pharma 2Edison Expands French Healthcare Sector Coverage With Initiation of Coverage on BioAlliance Pharma 3Mapi Pharma Granted United States Patent for Pain Relief Medication "Tapentadol" 2
... Feb. 26 Biomerix Corporation announced today that it ... clearance to market REVIVE(TM). Constructed using the Biomerix Biomaterial(TM), ... ingrowth and can be utilized in a variety of ... hernias. With more than 700,000 procedures per year, inguinal ...
... Feb. 26 ThermoGenesis, Corp. (Nasdaq: KOOL ), ... and store adult stem cells, said today that the FDA ... of certain lots of AXP disposable bagsets that it announced ... recall was not the result of any safety issues; the ...
... SOPHIA ANTIPOLIS, France, February 26 NicOx,S.A. (NYSE ... for,full year 2008 and provided an overview of ... investigational,drug for the treatment of the signs and ... Michele Garufi, Chief Executive Officer of NicOx, ...
Cached Biology Technology:Biomerix Corporation Announces FDA Clearance and Market Launch of REVIVE(TM) for Use in Soft Tissue Repair Procedures 2ThermoGenesis Says FDA Concurs with Plan for Previously Announced AXP(TM) Bagset Recall 2ThermoGenesis Says FDA Concurs with Plan for Previously Announced AXP(TM) Bagset Recall 3Financial Results for Full Year 2008: NicOx in a Unique Position to Deliver Significant Shareholder Value 2Financial Results for Full Year 2008: NicOx in a Unique Position to Deliver Significant Shareholder Value 3Financial Results for Full Year 2008: NicOx in a Unique Position to Deliver Significant Shareholder Value 4Financial Results for Full Year 2008: NicOx in a Unique Position to Deliver Significant Shareholder Value 5Financial Results for Full Year 2008: NicOx in a Unique Position to Deliver Significant Shareholder Value 6Financial Results for Full Year 2008: NicOx in a Unique Position to Deliver Significant Shareholder Value 7Financial Results for Full Year 2008: NicOx in a Unique Position to Deliver Significant Shareholder Value 8Financial Results for Full Year 2008: NicOx in a Unique Position to Deliver Significant Shareholder Value 9Financial Results for Full Year 2008: NicOx in a Unique Position to Deliver Significant Shareholder Value 10Financial Results for Full Year 2008: NicOx in a Unique Position to Deliver Significant Shareholder Value 11Financial Results for Full Year 2008: NicOx in a Unique Position to Deliver Significant Shareholder Value 12Financial Results for Full Year 2008: NicOx in a Unique Position to Deliver Significant Shareholder Value 13Financial Results for Full Year 2008: NicOx in a Unique Position to Deliver Significant Shareholder Value 14Financial Results for Full Year 2008: NicOx in a Unique Position to Deliver Significant Shareholder Value 15
(Date:6/17/2013)... in patients with severe brain infections in Vietnam. Further ... responsible for the symptoms of disease. , The virus ... 644 patients with severe brain infections in the study, ... the 122 patients with non-infectious brain disorders that were ... system are often fatal and patients who do survive, ...
(Date:6/17/2013)... in Wayne State University,s Department of Physics kicked ... Experience for Undergraduates (REU) program. This program aims ... research in astrophysics, and in particle and nuclear ... professor of physics in Wayne State,s College of ... of the grant, the student participants will work ...
(Date:6/17/2013)... , June 17, 2013 As mobile ... need to secure them grows exponentially, and biometric ... report from Heavy Reading Insider ( ... Heavy Reading ( www.heavyreading.com ). ... the market for biometric authentication on smartphones, analyzing ...
Breaking Biology News(10 mins):New virus isolated from patients with severe brain infections 2New virus isolated from patients with severe brain infections 3Wayne State welcomes undergraduates from around the US for physics research experience 2Biometric Authentication Provides Better Mobile Device Security, Heavy Reading Finds 2Biometric Authentication Provides Better Mobile Device Security, Heavy Reading Finds 3
... genetic screening (PGS) has been one,of the most hotly ... years. None of the trials,carried out so far has ... European Society of Human,Reproduction and Embryology (ESHRE) Task Force ... if a novel,method of doing PGS using polar body ...
... signal molecule made by the human body that triggers the ... according to new research published today in Nature Medicine ... say that if scientists could block this signal, it may ... arthritis is the most common autoimmune disease, affecting around 1 ...
... fans are in awe of what their football heroes can ... remains strangely mysterious. Although being in excellent physical condition undoubtedly ... can turn an average bloke into a Ronaldo. Now, scientists ... this "something else" might be. Dr. Robbie Wilson will talk ...
Cached Biology News:ESHRE launches international study of polar body screening 2New trigger for chronic inflammation in rheumatoid arthritis discovered 2What makes a great footballer? 2
... frozen Sf9 Insect Cells are derived from the ... for optimal growth, use in transfections, plaque assays, ... frozen in a protocol that optimizes recovery of ... growth in serum-free BacVector Insect Cell Medium and ...
... software package that provides crystallographers with ... buffer creation, set-up of experimental conditions ... The software helps crystallographers through the ... crystallography: Design of ...
... premium quality recombinant form of Thermus aquaticus ... for a wide range of PCR applications. ... performance, each preparation is extensively tested in ... DNA Polymerase possesses an integral 5′→3′ exonuclease ...
... direct antibiotic-based selection system for recombinant identification. ... eliminating the need for costly color screening. ... to 100% accuracy in recombinant selection. pLivSelect ... colony picking. This cloning kit can be ...
Biology Products: